Skip to main content
. 2020 Sep 23;9(9):e17684. doi: 10.2196/17684

Table 1.

Search terms.

Category MeSH terms Keywords (in title or abstract)
Brexit European Union, United Kingdom Brexit OR United Kingdom OR Britain OR ((“EU” OR “European Union”) AND “single market”) OR “Article 50” OR ((leave OR withdraw* OR exit OR remain OR stay) ADJ4 (“European Union” OR “EU” OR “EEA” OR “European Economic Area”)) OR “Post-Brexit”
Pharmaceuticals Drug industry, pharmaceutical preparations, pharmaceutical societies, pharmaceutical economics, drug approval, United States Food and Drug Administration ((Pharma* OR drug* or medic*) ADJ4 (industr* OR compan* OR supply OR sector OR production OR approval OR deliver* OR regulat* OR preparation* OR societ* OR econom* OR manufactur* OR shortage* OR stockpil* OR stock-pil*)) OR “EMA” OR “European Medicines Agency” OR “MHRA” OR “Medicines and Health products Regulatory Agency” OR “FDA” OR “Food and Drug Administration” OR “Royal Pharmaceutical Society” OR “National Health Service” OR “NHS” OR “Department of Health”
Effects Cost and cost analyses, time-to-treatment Consequence* OR change* OR outcome* OR effect* OR implication* OR result* OR opinion* OR cost* OR delay* OR “customs union” OR “free trade” OR “severe” OR “severity”